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Abstract. The purpose of our study was to evaluate the
presence of anatomical and functional damage to the afferent
and sensorial fibres using the Neurometer CPT test. A
questionnaire regarding pain was sent to 300 women who had
undergone surgery six months earlier. Out of 300 patients 67
did not respond; 105 experienced no pain; while 128 felt pain.
One hundred and twenty-eight women were divided into two
groups: mastectomy with reconstruction and simple
mastectomy. The intensity of pain at T0 in women with
reconstruction was significantly higher; at T4, on the other
hand, was lesser and there was no significant difference
between the two groups. In both groups at T4, the daily diary
revealed that interference with sleep and normal daily activities
were more evident in patients who had undergone
reconstruction (p>0.001). The final results at T4 demonstrated
that among patients with reconstruction, 47% showed slight
hypoesthesia-paraesthesia in the breast, armpit and arm zones,
39% slight hypoesthesia in the same locations and 18% severe
hypoesthesia. Patients with reconstruction, instead, showed
different percentages: 75% showed slight hypoesthesia-
paraesthesia, 16% a slight hypoesthesia and 9% severe
hypoesthesia. Our results support the utilization of the
Neurometer CPT test as a device for monitoring post-
mastectomy pain.
Post-mastectomy pain is a frequent occurrence in patients
who have undergone this type of surgery and it is estimated
to occur in about 10-30% of the cases (1-4). Pain is
manifested particularly during the 30-60 days following
surgery, after the post-operative period is over. Patients
experience heightened depression associated with the loss
of an organ, which has both functional and esthetic
implications. Post-mastectomy alterations in sensation and
chronic pain are an area of breast cancer therapy that has
not been extensively described. After the post-operative
period and once the acute pain has subsided, the
oncological-surgical team is inclined to treat the patient’s
painful symptoms as a temporary event. Pain persisting
longer than 7-8 months could indicate that irreversible
neurological damage has occurred during surgery. While the
incidence of pain after surgery is high, its basic processes
are not well known. Using conventional neuro-physiological
methods, it is difficult to widely document this occurence,
due to nerve damage and/or entrapment or compression
near the area subjected to surgery, which is likely
responsible for the spontaneous pain and alterations in
normal somato-sensorial stimuli (5).
The goal of this study was to use the Neurometer CPT
test to evaluate the presence of anatomical and functional
damage to the afferent and sensorial fibres A‚, A‰ and C
(6) and to investigate the correlation between the type of
surgical operation and the symptoms produced.
Materials and Methods
The clinical records of patients operated for breast cancer during
the six months previous to this writing at the IX Unit of the
General Surgery and Plastic Surgery Departments at the Second
University of Naples, Naples, Italy. The records were studied to
obtain data regarding the type of surgical operation, type of
reconstruction (if any), presence or not of an implant, type and
position of the implant, time of reconstruction (immediate or
postponed), cancer therapy and presence of pain and paraesthesia
at the time of the evaluation. 
Among the women who were interviewed (Figure 1), 128 (43%)
(median age 55±1.89 years) were included in our study. They were
then divided into two groups according to the type of operation:
mastectomy with reconstruction and simple mastectomy.
The exclusion criteria included: severe psychiatric and organic
disorders; metastases; lymph edema; radio- or chemotherapy;
rheumatoid and/or autoimmune arthritis; arthritis; Raynauld’s
disease; no pain or VAS ≤1.
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The inclusion criteria included: women who underwent an
unilateral breast cancer operation including removal of axillary lymph
nodes without recurrences; reconstruction with immediate implants
underlying the muscle (skin-sparing); no reconstruction; presence of
sensorial and/or painful chest problems; diseases in the area of the
incision, armpit, arm and ipsi-lateral hand; VAS ≥2. At the time of
screening, following written informed consent, an accurate patient’s
history was gathered, followed by a clinical-neurological examination
and by a McGill pain questionnaire to evaluate pain (short form) (7)
and VAS. ECG was used to exclude possible connections between
chest pain and cardiac pathology (8), and routine laboratory
screening for indicators of inflammation (sedimentation rates, C-
reaction protein, antistreptolysin) (9) were performed. The clinical-
neurological examination was completed bilaterally and symmetrically
by a consecutive evaluation of sensibility: tactile, superficial pain,
deep tactile, vibratory and deep pain sensibility. The study of each
patient lasted eight months. The sessions were conducted as follows: 
First session (T0): six months after the operation.
Second session (T1): 30 days after the first session.
Third session (T2): 60 days after the second.
Fourth session (T3): 60 days after the third.
Fifth session (T4): 90 days after the fourth.
The electro-diagnostic exam using the Neurometer CPT test
(Neuval Software) (10) was conducted by placing electrodes on the
painful areas (referring to the clinical exam), and along the
dermatometric distribution of the nervous fibers that had to be
evaluated (Figure 2). A CPT measurement represents the minimal
quantity of an electrical, neuro-selective, trans-cutaneous
nonpainful stimulant required to evoke a sensation. Neuro-
selectivity was obtained by the application of sinusoidal electrical
stimulation of different frequencies. Each site was examined by the
use of three different electro-stimulation frequencies: 2000, 250
and 5 Hz. In this manner, the stimulation of large and small
myelinic fibers and amyelinic fibers was obtained. As such, three
values independent of the CPT test were obtained and
appropriately registered in the software database, stored and
evaluated, based on the condition of the tested nerves.
In our study, the CPT exam was performed by positioning
electrodes on the standard terminations and related algogenic areas,
by delivering a current of 5, 250 and 2,000 Hz. We proceeded in an
antidromic direction along the distribution pathways of the nervous
structures. The electrodes were positioned on the following sites:
the back of the hand, the forearm, arm, deltoid muscle, chest and
breast (Figure 2). The threshold of perception to different electrical
stimulations, calculated by a computerized system, allowed us to
distinguish among the following conditions: no pain, slight or
moderate discomfort and slight, moderate or severe hypoesthesia
to complete anesthesia. During each visit, the patients underwent a
clinical neurological examination, and completed the McGill pain
questionnaire and CPT test. Their monthly diary was read for a
daily evaluation of their pain, intake of the prescribed medicines
(NSAIDs if necessary) and other aspects, such as interference with
sleep and daily activities.
The student’s t-test, at a confidence interval of 95%, was used
to compare the values for pain intensity, average age, neurological
examination and daily diary. The results of all tests were
considered statistically significant at p<0.05. The ¯2-test was used
to evaluate the association between the degree of pain documented
with the Neurometer at time T4 and the type of plastic surgery
performed. 
The "null" hypothesis can be formulated, asserting that there is
no association between the degree of pain documented with the
Neurometer and the type of plastic surgery; the alternative
hypothesis (Ha) is that there is an important link. The ¯2-test was
used and the level of significance was set at ·=0.05 with gl=(r-l)
(C-1) for a distribution ¯2 with gl=2, p<0.01. When p<·, the "null"
hypothesis was ruled out and it was concluded that there was a
significant association between the presence of pain at T4
evaluated with the CPT test and the type of surgical operation. The
tests were performed using the SPSS program (version 11.0) for
Windows. 
Results
Out of the 300 patients to whom the questionnaire was
sent, 67 (22%) did not respond, 105 (35%) did not
mention pain, while 128 (43%) spoke of pain. The age
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Figure 1. Questionnaire.
(average±SD) of both groups is shown in Table I. The age
of patients who accepted reconstruction was significantly
lower (p<0.0001) than those without reconstruction.
Regarding the blood tests performed at T0, more than
one of inflammation was highly evident in both groups, for
all patients (Tables I, II, III).
The intensity of pain expressed using the VAS score was
significantly higher at T0 (p<0.0001) in patients with
reconstruction (5.26±1.33) compared to those who had
undergone a simple mastectomy (4.27±1.9) (Figure 3).
Overlapping values, instead, were shown at T4 for both
groups (VAS mastectomy and reconstruction = 2.66±1.33;
VAS simple mastectomy = 2.53±1.01) and no significant
difference was found (p<0.53) (Figure 4). In addition the
patients with mastectomy and reconstruction did not show
significant differences in their description of sensorial pain
compared to patients who underwent mastectomy only
(Table IV, Figure 5).
During the neurological examination at T0, patients in
the group who had undergone mastectomy and
reconstruction revealed the following: allodynia in the area
near the wound (95%), negative pin-prick test in the breast
area (87%), negative pin-prick test at the level of the homo-
lateral upper limb (56%) and/or presence of alterations in
vibratory perception in the breast area (75%).
Those patients with simple mastectomy, instead, revealed
the following: allodynia in the area near the wound (85%),
negative pin-prick test in the breast area (75%), negative
pin-prick test at the level of the homo-lateral upper limb
(46%) and/or presence of alterations in vibratory perception
in the breast area (35%) (Table V).
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Figure 2. Electrodes position along the dermatomeric distribution of the nervous fibers that had to be evaluated.
Table I. Median age of the patients of the two groups studied.
Mastectomy +  Mastectomy P-value
reconstruction
Age (years± SD) 48±2.21 62±1.58 p<0.0001
Table II. Indicators of inflammation at time T0.
Mastectomy + Mastectomy 
reconstruction
C-reaction protein 12 mg/L 11 mg/L
Sedimentation rates 32 mm/h 32 mm/L
Antistreptolysin <330 U/mL <330 U/mL
Leucocytes 12.8x109 L 11.8x109 L
Neutrophiles 8x109 cell/L 7.9x109 cell/L
Table III. Indicators of inflammation at time T4.
Mastectomy + Mastectomy 
reconstruction
C-reaction protein 9 mg/L < 8 mg/L
Sedimentation rates 31 mm/h < 30 mm/L
Antistreptolysin < 330 U/mL < 330 U/mL
Leucocytes 11.8x109 L 10.8x109 L
Neutrophiles 7.8x109 cell/L 6.5x109 cell/L
The final results of the neurological examination at T4 in
the mastectomy + reconstruction group showed: allodynia
in the pericicatrizating area (85%), negative pin-prick test
at the level of the homo-lateral upper limb (35%), negative
pin-prick test in the breast area (67%) and/or presence of
alterations in vibratory perception in the breast area (61%).
The same exam in the group of patients who had
undergone a simple mastectomy revealed: allodiny in the
pericicatrizating area (59%), negative pin-prick in breast
(37%) unaltered pin-prick at the level of the upper homo-
lateral limb (37%), and/or no alteration in vibratory
perception in the breast area (68%) (Table VI).
The final results at time T4 with the Neurometer CPT
test indicate that among patients with reconstruction, 47%
had a slight hypoesthesia-paresthesia in the areas of the
breast, armpit and homo-lateral limb, 35% a moderate
hypoesthesia in the same anatomical regions and at least
18% had severe hypoesthesia. On the other hand, patients
without reconstruction showed different results, at the
same time and in the same anatomical regions: 75% noted
slight hypoesthesia, 16% noted moderate hypoesthesia and
9% severe hypoesthesia (Table VII).
At time T0, the Neurometer showed a score of 9.54 and
of 2.65 at T4 (a score of 0 was normal) (p<0.01) (Table
VIII).
The results obtained from the daily diary of both groups
at T4 showed that interference with both sleep and normal
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Table IV. Distinctive features of pain.
Description of pain Mastectomy + Mastectomy
reconstruction
1. throbbing 3 8
2. like a spring, it goes off 0 0
3. it is like a stab 0 0
4. it is sharp like a razor-blade 0 0
5. gnawing 0 0
6. cramping 8 3
7. hot/burning 27 20
8. causes suffering 22 27
9. oppressive 18 15
10. sensitive to touch 5 10
11. splitting 7 8
12. tiring/exhausting 10 9
13. repulsive 0 0
14. alarming 0 0
15. vexes- it is cruel 0 0
Each number is the percentage of patients who gave a positive answer
to the description of the type of pain.
Figure 3. Pain measurement at time T0.
Figure 4. Pain measurement at time T4.
Figure 5. Features of pain.
daily activities was more relevant in patients with
mastectomy with reconstruction than in those with simple
mastectomy. A significant difference was shown (p<0.001)
(Table IX).
Discussion
Several theories regarding the mechanisms of sensorial
disease and pain after a trauma can be applied to our study.
The whole innervation of the breast in association with
the brachial plexus is anatomically complex. The nerves
running through the deep musculature of the thoracic
wall include the long thoracic, dorsal thoracic, lateral
pectoral, and the median pectoral nerve. These nerves
are usually unbridled during a mastectomy and can be
traumatized (11). Also, the manipulation of the skin,
which is richly innervated, can be the cause of pain along
the cicatrix (12).
At the beginning of our study, we predicted that pain
following reconstruction and dysesthesia after six months
would disappear spontaneously. Our study, however,
demonstrates that pain regressed while sensorial dysfunction
remained, as confirmed by the CPT test at T4. There are
some possible explanations for this result. The higher
incidence of this kind of problem in the group of
reconstructed patients could be due to a wider surgical
dissection made to better insert the implant. Focal traumas
can cause short interruptions in demyelinization that
generate primary and secondary activity with a rise in axonal
sprout (13). The scarring and chronic compression, with
subsequent ischemia, can cause alterations in large and small
myelinic fibers (14). The lateral and median pectoral nerve
and the long thoracic nerve derive from the brachial plexus
and extend under the large pectoral muscle. In the implants,
beneath the muscle, the formation of a capsule that is not
reactive can cause a compression. We are inclined to reject
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Table V. Results of the clinical neurological examination at T0.
Mastectomy + Mastectomy P-value
reconstruction
Presence ofallodynia Yes (95%) Yes (85%) p<0.23
in the cicatrix area
Pin-prick test in Pin-prick  Pin-prick  p<0.10
the breast area negative (87%) negative (75%)
Pin-prick homo- Pin-prick negative Unaltered 
lateral upper limb (56%) (46%)
Presence of alterations Yes (75%) No (35%) p<0.10
in vibratory perception 
in breast area
Table VI. Final results of the clinical neurological examination at T4.
Mastectomy +  Mastectomy P-value
reconstruction
Presence of allodynia Yes (85%) Yes (59%) p<0.001
in the cicatrix area
Pin-prick test in Pin-prick Pin-prick p<0.001
the breast area negative (67%) negative (37%)
Pin-prick homo-lateral Pin-prick Unaltered 
upper limb negative (35%) (65%)
Presence of alterations Yes (61%) No (68%) p<0.001
in vibratory perception 
in breast area
Table VII. Final results of the Neurometer CPT test at T4 (breast area,
armpit and homo-lateral limb).
Slight Moderate Severe Total
hypoesthesia hypoesthesia hypoesthesia
Mastectomy + 
reconstruction 29 22 11 62
Mastectomy 50 10 6 66
Total 79 32 17 128
¯2-test p<0.01
Table VIII. Sensitivity.
Nerves that returned 
to normal function 3 (33.4%) 5 (55.7%) p<0.01
Better nerves 1 (11.1%) 2 (22.1%) p<0.01
Worse nerves 3 (33.4%) 1 (11.1%) p<0.05
Stationary nerves 2 (22.1%) 1 (11.1%) p<0.05
Total of studied nerves 9 (100%) 9 (100%)
Table IX. Final results of the daily diary at T4.
Mastectomy +  Mastectomy P-value
reconstruction
Interference with sleep Yes (↓↓) No p<0.001
Pain Slight Slight
Interference with daily activities Yes (↓↓) No p<0.001
this hypothesis, since the signs of phlogosis at the time the
blood tests were performed were not statistically significant.
The common sign of significant hypoesthesia revealed by
the Neurometer confirms a mechanical compressive effect
in patients with reconstruction.
The CPT is used for two types of analysis including an
analysis of the range of the neuropathy, from hyperesthesia
to hypoesthesia, to compare the values of the area tested
with normal values at 2,000Hz, 250Hz and 5Hz as well as
an analysis of the ratio calculated to evaluate the values
obtained for each frequency. The two types of ratio analysis
available with CPT are either: a) between sites, comparing
the ratio with counterlateral sites, or b) within the same
site, comparing the different frequencies obtained from the
CPT itself.
The evaluation of the ratio indicated a sensory
dysfunction on the first stage, while analysis of the range
showed the functional damage. Low values of the CPT test
indicate an alteration in nervous function (hyperesthesia),
while high values denote the loss of nervous function
(hypoesthesia).
The threshold of perception of different electrical
stimuli, analyzed by a computerized system, allowed us to
observe the following: no anomalies; slight or moderate
sensory dysfunction, slight or moderate hyperesthesia;
slight, moderate or serious hypoesthesia, up to complete
anesthesia. The McGill pain questionnaire was used to
record any peculiarities in the patients’ pain. It is well
known that high anxiety levels and other emotional factors
can affect the value of the questionnaire.
There was no significant difference found between the
two groups in our study, probably because the breast
reconstruction reduced the anxiety and depression normally
caused by post-surgical impairment. Reconstruction was
reported to improve the patient’s emotional state, self
image and sex life (15).
Conclusion
Our results suggest the use of the CPT Neurometer test
as a valid electro-diagnostic exam in patients suffering
from post-mastectomy pain. This procedure is not
painful and is economically favorable. Our goal is to
continue to expand our study to the screening of a large
group of women and to longitudinal evaluations during
clinical trials.
We are convinced that algological studies, following
oncological and surgical treatment, could be a third
component in the multi-modal therapy of breast cancer.
Such studies could be extremely useful in identifying
relevant problems connected with this pathology and,
therefore, ultimately in improving therapy.
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